<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7457578\results\search\drug\results.xml">
  <result pre="being used by the majority (50.5%) was DMARDs (methotrexate and" exact="sulfasalazine" post="alone or in combination). Immunosuppressant therapy (cyclophosphamide, mycophenolate mofetil,"/>
  <result pre="(methotrexate and sulfasalazine alone or in combination). Immunosuppressant therapy (cyclophosphamide," exact="mycophenolate mofetil," post="or azathioprine) and biological agents (adalimumab, etanercept, or tofacitinib)"/>
  <result pre="those with symptomatic infections only. Some commonly used drugs like" exact="hydroxychloroquine" post="might have some role in inhibition of SARS-CoV-19 by"/>
  <result pre="Dis. 2020;23(6):717â€&quot;722. doi:10.1111/1756-185X.1386332462761 14.WangM, CaoR, ZhangL, et al. Remdesivir and" exact="chloroquine" post="effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in"/>
 </snippets>
</snippetsTree>
